Universidad de Valencia
Valencia, 46010, Spain
NCT Number: NCT02726516
Compare a dietary supplement (PRJ-205) and placebo during 1 or 4 days on aerobic exercise performance, oxidative stress and muscle damage.
The hypothesis is that supplementation with PRJ-205 improve aerobic performance
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Valencia, 46010, Spain
Twenty young active males will be recruited and randomized to either placebo or PRJ-205. Subjects will take the designated treatment in an acute dosage and chronically, 4 days of treatment.
They will undergo 3 exercise tasks (before the administration of the product, 1.5h after the acute administration of the product and after 4 days of treatment). VO2max and anaerobic threshold will be measured during the tests. Blood samples will be taken to measure muscle damage and oxidative stress.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 sachet per day
1 sachet per day
Time frame: 4 days
Time frame: 4 days
Measured pre- and post- exercise task
Time frame: 4 days
Measured from blood samples taken pre- and post- exercise task.
Time frame: 4 days
Measured from blood samples taken pre- and post- exercise task.
Bioiberica
Industry
Effects of PRJ-205 on Performance in Trained Young Subjects After Acute and Chronic Intake of the Study Product
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details